Evidence map›Paper›PMID 36303187›Full record

ArticleVirology journal2022

Case report: BA.1 subvariant showing a BA.2-like pattern using a variant-specific PCR assay due to a single point mutation downstream the spike 69/70 deletion.

Carlos Daviña-Nuñez, Sonia Pérez-Castro, Lucía Martínez-Lamas, Jorge Julio Cabrera-Alvargonzález, Sonia Rey-Cao, Raquel Carballo-Fernandez, Montse Godoy-Diz, Leticia López-Bóveda, Victor Del Campo-Pérez, Silvia Suárez-Luque and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Virology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Carlos Daviña-Nuñez *Universidade de Vigo. Microbiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Vigo, Spain.ORCID 0000-0001-6952-2219
Sonia Pérez-Castro *Microbiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur). Microbiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain. sonia.maria.perez.castro@sergas.es.ORCID 0000-0003-1734-1904
Lucía Martínez-LamasMicrobiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur). Microbiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Jorge Julio Cabrera-AlvargonzálezMicrobiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur). Microbiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.ORCID 0000-0002-0397-0868
Sonia Rey-CaoMicrobiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur). Microbiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Raquel Carballo-FernandezMicrobiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Montse Godoy-DizMicrobiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Leticia López-BóvedaMicrobiology Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Victor Del Campo-PérezRheumatology and Immune-mediated Diseases Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur). Preventive Medicine Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Silvia Suárez-LuqueDirección Xeral de Saúde Pública, Xunta de Galicia, Consellería de Sanidade, Santiago de Compostela, A Coruña, Spain.
Benito Regueiro-GarcíaMicrobiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Vigo, Spain.ORCID 0000-0002-4009-7922
University Hospital Complex Of Vigo · ESGalicia Sur Biomedical Foundation · ESXunta de Galicia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 variant tracking is key to the genomic surveillance of the COVID-19 pandemic. While next-generation sequencing (NGS) is commonly used for variant determination, it is expensive and time-consuming. Variant-specific PCR (vsPCR) is a faster, cheaper method that detects specific mutations that are considered variant-defining. These tests usually rely on specific amplification when a mutation is present or a specific melting temperature peak after amplification. CASE PRESENTATION: A discrepant result between vsPCR and NGS was found in seventeen SARS-CoV-2 samples from Galicia, Spain. A cluster of BA.1 Omicron SARS-CoV-2 variant showed a BA.2-like melting temperature pattern due to a point mutation (C21772T) downstream the deletion of the spike amino acids 69/70. As the 69/70 deletion is widely used for differentiation between BA.1 and BA.2 by vsPCR, C21772T can cause BA.1 samples to be misinterpreted as BA.2. Over a thousand BA.1 sequences in the EpiCoV database contain this mutation.

conclusionsTo our knowledge, this is the first case of a point mutation causing a vsPCR algorithm to misclassify BA.1 samples as BA.2. This is an example of how mutations in the probe target area of vsPCR tests based on melting curve analysis can lead to variant misclassification. NGS confirmation of vsPCR results is relevant for the accuracy of the epidemiological surveillance. In order to overcome the possible impact of novel mutations, diagnostic tools must be constantly updated.

Indexed as

COVID-19SARS-CoV-2HumansMutationPandemicsPoint MutationPolymerase Chain ReactionBA.1BA.4BA.5Next generation sequencingOmicronSARS-CoV-2SurveillanceVariant-specific PCR

Identifiers

PMID36303187
PMCPMC9610356
OpenAlexW4307640323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.